Five-year results of a phase II study with low-dose bacille calmette-guerin therapy in high-risk superficial bladder cancer

Author: Mack D.   Frick J.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.45, Iss.6, 1995-06, pp. : 958-961

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract